Education
About Us
Working with TipRanks
Follow Us
Centessa Pharmaceuticals (CNTA)
NASDAQ:CNTA
Serpinpc
Hemophilia B, Hemophilia A, Hemophilia A With Inhibitor, Hemophilia B With Inhibitor
Phase III
Terminated
The Long-term Safety and Efficacy of SerpinPC in Subjects with Hemophilia Who Completed a Sponsored SerpinPC Clinical Trial
Aug 21, 2024
―
Serpinpc
Hemophilia B, Hemophilia B With Inhibitor
Phase II
Terminated
A Study of SerpinPC in Participants with Hemophilia B (HemB) with Inhibitors
Mar 16, 2023
―
Serpinpc
Hemophilia B, Hemophilia A
Phase II
Terminated
The Efficacy and Safety of SerpinPC in Participants with Severe Hemophilia a or Moderately Severe to Severe Hemophilia B
Mar 16, 2023
―
Cbs001
Chronic Inflammatory Disease
Phase I
Terminated
Study of Intravenously Administered Anti-LIGHT Monoclonal Antibody CBS001 in Healthy Volunteers
Apr 05, 2022
―
Lixivaptan
Polycystic Kidney Disease, Adult
Phase III
Terminated
Roll-over Study to Assess Safety of Lixivaptan in Participants With ADPKD Who Completed Study PA-ADPKD-303
Jan 07, 2022
―
Zf874
Alpha1 Anti-Trypsin Deficiency
Phase I
Terminated
A Single Ascending and Repeated Dose Study of Oral ZF874 in Healthy Volunteers and PiXZ Subjects
Jun 16, 2020
―
Lixivaptan
Adpkd, Polycystic Kidney Disease, Adult
Phase III
Terminated
Safety of Lixivaptan in Subjects Previously Treated With Tolvaptan for Autosomal Dominant Polycystic Kidney Disease
Oct 31, 2019
―
Lixivaptan
Autosomal Dominant Polycystic Kidney, Adpkd
Phase III
Terminated
Efficacy and Safety of Lixivaptan in the Treatment of Autosomal Dominant Polycystic Kidney Disease
Aug 19, 2019
―
Serpinpc
Hemophilia B, Hemophilia A
Phase I/II
Completed
The Safety and Tolerability of SerpinPC in Healthy Men and in Men with Severe Blood Disorders (haemophilia a and B)
Aug 13, 2019
―
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Centessa Pharmaceuticals (CNTA) have in its pipeline
CNTA is currently developing the following drugs: Serpinpc, Serpinpc, Serpinpc. These drug candidates are in various stages of clinical development as the company works toward FDA approval.